- Home
- BWMX vs RAPT Comparison
BWMX vs RAPT Comparison
Compare BWMX & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMX
- RAPT
- Stock Information
- Founded
- BWMX 1995
- RAPT 2015
- Country
- BWMX Mexico
- RAPT United States
- Employees
- BWMX N/A
- RAPT N/A
- Industry
- BWMX Catalog/Specialty Distribution
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- BWMX Consumer Discretionary
- RAPT Health Care
- Exchange
- BWMX Nasdaq
- RAPT Nasdaq
- Market Cap
- BWMX 495.6M
- RAPT 498.4M
- IPO Year
- BWMX N/A
- RAPT 2019
- Fundamental
- Price
- BWMX $14.20
- RAPT $29.78
- Analyst Decision
- BWMX Strong Buy
- RAPT Strong Buy
- Analyst Count
- BWMX 2
- RAPT 9
- Target Price
- BWMX $22.50
- RAPT $54.33
- AVG Volume (30 Days)
- BWMX 46.5K
- RAPT 695.0K
- Earning Date
- BWMX 10-23-2025
- RAPT 11-12-2025
- Dividend Yield
- BWMX 10.25%
- RAPT N/A
- EPS Growth
- BWMX 15.49
- RAPT N/A
- EPS
- BWMX 1.49
- RAPT N/A
- Revenue
- BWMX $775,128,445.00
- RAPT N/A
- Revenue This Year
- BWMX $6.21
- RAPT N/A
- Revenue Next Year
- BWMX $6.10
- RAPT N/A
- P/E Ratio
- BWMX $9.53
- RAPT N/A
- Revenue Growth
- BWMX 3.60
- RAPT N/A
- 52 Week Low
- BWMX $7.00
- RAPT $5.67
- 52 Week High
- BWMX $15.00
- RAPT $42.39
- Technical
- Relative Strength Index (RSI)
- BWMX 62.70
- RAPT 60.07
- Support Level
- BWMX $12.50
- RAPT $29.36
- Resistance Level
- BWMX $15.00
- RAPT $31.00
- Average True Range (ATR)
- BWMX 0.61
- RAPT 3.32
- MACD
- BWMX 0.18
- RAPT -0.46
- Stochastic Oscillator
- BWMX 69.98
- RAPT 30.48
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.